Thermal Breast Imaging PMA Review Biased, CTI Citizen Petition Contends
This article was originally published in The Gray Sheet
Executive Summary
Computerized Thermal Imaging wants to investigate the non-approval of its BCS 2100 PMA and introduce new information to the administrative record
You may also be interested in...
CTI Breast Imaging System Panel Review Falters On Retrospective Analysis
Computerized Thermal Imaging, Inc.'s "post-hoc," retrospective analysis of breast masses viewed with the BCS 2100 thermal breast imaging system failed to convince FDA's Radiological Devices Advisory Panel of the device's effectiveness
Lifecore Intergel Approvable Despite FDA Objections, MDDR Panel Says
Lifecore Biomedical's Gynecare Intergel adhesion prevention solution appears closer to FDA approval following a determination by the agency's Medical Devices Dispute Resolution Panel (MDDRP) that the firm demonstrated a statistically significant treatment effect.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.